INS and obesity disorder: In contrast, GPR43 induces glucose-dependent insulin discharge, inhibits glucagon secretion, improves insulin sensitivity, reduces hepatic gluconeogenesis, and controls appetite (Figure 1a).26 Furthermore, SCFAs can prevent obesity and IR by shifting from lipogenesis to fatty acid oxidation in the liver and adipose tissue.